CORT Q1 2019 Earnings — Corcept Therapeutics Incorporated Revenue & Financial Results | Market Cap Arena

CORTCorcept Therapeutics Incorporated

$4B

Q1 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$65M+12.4% YoY

Gross Profit

$64M98.1% margin

Operating Income

$19M29.2% margin

Net Income

$18M28.2% margin

EPS (Diluted)

$0.15

QoQ Revenue Growth

-3.0%

Cash Flow

Operating Cash Flow

$24M

Free Cash Flow

$23M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$320M

Total Liabilities

$34M

Stockholders' Equity

$286M

Cash & Equivalents

$50M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$65M	$58M	+12.4%
Gross Profit	$64M	$56M	+12.6%
Operating Income	$19M	$21M	-9.7%
Net Income	$18M	$17M	+4.7%